Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 23 Feb 24 424B2 Prospectus for primary offering
- 21 Feb 24 424B2 Prospectus for primary offering
- 2 Mar 23 424B2 Prospectus for primary offering
- 27 May 21 424B2 Prospectus for primary offering
- 24 May 21 424B2 Prospectus for primary offering
-
24 May 21 F-3ASR Automatic shelf registration (foreign)
AZN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form F-3 of AstraZeneca plc and AstraZeneca Finance LLC of our report dated February 11, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in AstraZeneca plc’s Annual Report on Form 20-F for the year ended December 31, 2020. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
London, United Kingdom
May 24, 2021